Plaintiff and appellant Ulta Salon, Cosmetics & Fragrance, Inc. (Ulta), appeals an order of dismissal following the sustaining without leave to amend of a demurrer interposed by defendant and respondent Travelers Property Casualty Company of America (Travelers) to Ulta's first amended complaint.
The essential issue presented in this insurance coverage action is whether the trial court properly held Travelers had no duty to defend or indemnify Ulta, its insured, in an underlying action against Ulta alleging violations of Proposition 65, the California Safe Drinking Water and Toxic Enforcement Act of 1986. (Health & Saf. Code, § 25249.5 et seq.)
On or about April 17, 2006, Travelers issued a $10 million commercial ceneral liability policy to Ulta, a nail products manufacturer, affording Ulta coverage from March 15, 2006, to March 15, 2007 (the policy).
The policy required Travelers to defend "any suit" against Ulta seeking damages that Ulta "becomes legally obligated to pay as damages because of `bodily injury' or `property damage.'" The policy defines "bodily injury" as "bodily injury, sickness or disease sustained by a person, including death resulting from any of these at any time."
On August 15, 2007, one Christine Deubler filed the underlying action "on behalf of the general public" against numerous manufacturers, distributors and/or sellers of nail products, including Ulta, seeking civil penalties and injunctive relief. The Deubler complaint contained a single cause of action for violation of Proposition 65, based on allegations the defendants' nail products contain DBP (dibutyl phthalate), a reproductive toxin, and that the State of California in December 2005 officially listed DBP as a chemical known to cause reproductive toxicity. The complaint alleged the defendants knew their respective nail products contain DBP, that consumers are exposed to DBP through the intended and foreseeable use of the nail products, and that the defendants failed to give consumers a clear and reasonable warning regarding the reproductive toxicity caused by exposure to DBP.
On or about October 8, 2007, Ulta received notice of the Deubler lawsuit. Ulta notified Travelers of the suit, provided Travelers with a copy of the complaint, and requested that Travelers defend and indemnify Ulta pursuant to the terms of the policy. On October 17, 2007, Travelers denied coverage of the Deubler lawsuit. On January 7, 2009, Travelers reiterated its denial, in response to a December 2, 2008 request by Ulta that Travelers withdraw its letter denying coverage.
Ulta allegedly incurred $241,684 to defend against the Deubler lawsuit, as well as $25,000 to settle the lawsuit, for a total of $266,684.
On October 16, 2009, Ulta commenced this action against Travelers, and filed the operative first amended complaint on January 4, 2010. Ulta pled causes of action against Travelers for breach of contract, declaratory relief, breach of the implied covenant of good faith and fair dealing, and tortious breach of the implied covenant of good faith and fair dealing. Ulta alleged Travelers at all times was obligated to defend and indemnify it under the policy, and that Travelers's refusal to perform its obligations was unreasonable and in bad faith.
Travelers demurred to the first amended complaint, contending it had no duty to defend or indemnify Ulta under the policy because the policy only afforded coverage for sums Ulta became legally obligated to pay as damages because of bodily injury or property damage, and the Deubler lawsuit did not allege bodily injury or property damage. The Deubler lawsuit solely sought civil penalties under Proposition 65 and injunctive relief, and those forms of relief were not covered or potentially covered damages under the policy. Further, absent a duty to defend, there can be no bad faith.
In its opposition papers, Ulta contended the Deubler complaint alleged facts giving rise to the potential for coverage. Ulta argued that although the Deubler complaint originally was brought to pursue civil penalties for Ulta's failure to warn about nail products containing DBP, "the face of the [Deubler] complaint also includes allegations regarding exposure to DBP, which purportedly is a chemical `known to cause cancer,' that caused birth defects and was `known to cause reproductive toxicity.' ... Thus, the facts as found on [the] face of the [Deubler] complaint potentially give rise to bodily injury claims. Bodily injury is squarely within the realm of `potentialities' of pleading and it is fairly inferable that Deubler contemplated bodily harm as a result of the alleged Proposition 65 violation."
Ulta further argued civil penalties constitute covered damages under the policy, and that the policy contains no exclusion for civil penalties.
On March 16, 2010, after hearing the matter, the trial court sustained Travelers's demurrer to the first amended complaint without leave to amend. The trial court's rationale is set forth in its minute order, which states in pertinent part:
"The policy provides coverage only for sums that Ulta `becomes legally obligated to pay as damages because of "bodily injury" or "property damage."' In the underlying Deubler lawsuit, Deubler asserted a single cause of action for violation of Proposition 65 for which she, on behalf of the general public, sought injunctive relief and penalties as provided [in] Health & Safety Code § 25249.7. There was no allegation that Deubler or any other person had suffered bodily injury as a result of exposure to any of Ulta's products or that they were even exposed to Ulta's products. `[Proposition 65] is informational and preventative rather than compensatory in its nature and function. The statutory damages available under the Act in the nature of civil penalties do not grow out of a claim for moneys due and owing or for personal harm or property damages that have resulted from discharge of pollutants or other toxic chemicals.... [Citations.] Rather, Proposition 65 is distinguishable in its fundamentally equitable purpose and remedy: to facilitate the notification of the public of potentially harmful substances, so informed decisions may be
Further, "[g]iven the nature of the Deubler complaint, any assertions that Deubler could have amended the complaint to assert a personal injury claim are unsupported speculation, where there is no showing that Deubler suffered any personal harm, that she was exposed to an Ulta product containing DBP, and that she suffered any bodily injury from such exposure, and that she could have but chose not to allege these facts. Because the underlying complaint did not seek covered damages, there was no potential for coverage."
In addition to finding Ulta had failed to state a cause of action, the trial court denied leave to amend, finding Ulta had not met its burden to show in what manner it could amend the complaint and how that amendment would change the legal effect of its pleading. "Because of the allegations of the complaint in Deubler, Ulta has not met this burden and cannot do so, absent tenuous and farfetched speculation about unpled facts in an underlying case that has been settled."
This appeal followed.
Ulta contends the trial court erred in sustaining the demurrer because there was a potential for coverage, and that the trial court abused its discretion in sustaining the demurrer without leave to amend because there is a reasonable possibility that amendment could cure any defect in the pleading.
In determining whether a plaintiff has properly stated a claim for relief, "our standard of review is clear: `"We treat the demurrer as admitting all material facts properly pleaded, but not contentions, deductions or conclusions of fact or law. [Citation.] We also consider matters which may be judicially noticed." [Citation.] Further, we give the complaint a reasonable interpretation, reading it as a whole and its parts in their context. [Citation.] When a demurrer is sustained, we determine whether the complaint states facts sufficient to constitute a cause of action. [Citation.] And when it is sustained without leave to amend, we decide whether there is a reasonable possibility that the defect can be cured by amendment: if it can be, the trial court has abused its discretion and we reverse; if not, there has been no abuse of discretion and we affirm. [Citations.] The burden of proving such reasonable possibility is squarely on the plaintiff.' [Citations.]" (Zelig v. County of Los Angeles (2002) 27 Cal.4th 1112, 1126 [119 Cal.Rptr.2d 709, 45 P.3d 1171].) Our review is de novo. (Ibid.)
The Deubler complaint alleged it was brought "on behalf of the general public" pursuant to section 25249.7.
In an attempt to show a potential for coverage, Ulta asserts that although the Deubler complaint "may have originally been brought to pursue a penalty for [Ulta's] failure to warn about nail products containing DBP[, n]evertheless, this does not preclude potential for coverage based on actual allegations regarding exposure to DBP. ... It is apparent from the pleading that Deubler contemplated bodily harm when bringing her Proposition 65 cause of action by repeatedly emphasizing the toxic nature of products allegedly manufactured or sold by [Ulta]. As such, the facts as found on the face of the complaint give rise to potential bodily injury claims."
Therefore, Travelers had no duty to defend based on unpled claims by Deubler that might implicate the policy.
Finally, Ulta proffers extrinsic evidence on appeal to show a reasonable possibility it is capable of amending the pleading to cure any defect with respect to Travelers's obligation to defend the Deubler action. (See fn. 3, ante.) Specifically, Ulta relies on the following:
(2) In Deubler's discovery responses, she asserted bodily injury could result from exposure of DBP through application via fingernails, toenails and human skin, and that studies showed "percutaneous absorption of chemicals," i.e., absorption of chemicals through the skin.
(3) An expert witness declaration by Dr. James Embree, a toxicologist, opined consumer exposure to DBP could occur due to direct dermal contact with the nail polish or through inhalation of DBP released from the applied polish.
(4) In the settlement agreement between Deubler and Ulta, Deubler released all current and future claims against Ulta, including all claims of bodily injury.
Ulta's reliance on this proffer of extrinsic evidence is unavailing for a number of reasons.
First, "the extrinsic facts which may create a duty to defend must be known by the insurer at the inception of the third party lawsuit ...." (Gunderson, supra, 37 Cal.App.4th at p. 1114.) There is no contention by Ulta that Travelers had timely knowledge of the above facts.
Moreover, the extrinsic evidence shows at most that Deubler may have been exposed to an Ulta product containing DBP. However, mere exposure to a chemical that may cause cancer, birth defects, or other reproductive harm, is not the same as suffering bodily injury as a consequence of such exposure. The Deubler lawsuit pled nothing more than a failure to give clear and reasonable warnings in violation of Proposition 65.
Ulta would have this court infer from the discovery responses in the Deubler action that plaintiff Deubler "contemplated bodily injury and her complaint could have very likely been amended to include bodily injury claims." The argument fails. As discussed, "[a]n insured may not trigger the duty to defend by speculating about ... ways in which the third party claimant might amend its complaint at some future date." (Gunderson, supra, 37 Cal.App.4th at p. 1114, italics added.)
The trial court is directed to enter, nunc pro tunc as of March 16, 2010, an order of dismissal. That order is affirmed. Travelers shall recover its costs on appeal.
Croskey, J., and Kitching, J., concurred.
Section 25249.11 provides in relevant part at subdivision (f): "`Warning' within the meaning of Section 25249.6 need not be provided separately to each exposed individual and may be provided by general methods such as labels on consumer products, inclusion of notices in mailings to water customers, posting of notices, placing notices in public news media, and the like, provided that the warning accomplished is clear and reasonable." (Italics added.)